Oruc, C. U. Et Al. 2017. Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome. CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.55, no.1 , 139-144.

Oruc, C. U., Akpinar, Y. E., Dervisoglu, E., Amikishiyev, S., Salmaslioglu, A., Gurdol, F., ... Omer, B.(2017). Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome. CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.55, no.1, 139-144.

Oruc, Coskun Et Al. "Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome," CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.55, no.1, 139-144, 2017

Oruc, Coskun U. Et Al. "Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome." CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.55, no.1, pp.139-144, 2017

Oruc, C. U. Et Al. (2017) . "Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome." CLINICAL CHEMISTRY AND LABORATORY MEDICINE , vol.55, no.1, pp.139-144.

@article{article, author={Coskun U. Oruc Et Al. }, title={Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome}, journal={CLINICAL CHEMISTRY AND LABORATORY MEDICINE}, year=2017, pages={139-144} }